0 CHECKOUT

Bone Graft Substitutes - Global Strategic Business Report

  • ID: 992759
  • April 2016
  • Region: Global
  • 217 Pages
  • Global Industry Analysts, Inc
1 of 3

The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Bone Graft Substitutes in US$ Million. The US market is further analyzed by the following Segments: Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Stem Cell Based Bone Grafts, and Synthetic Bone Grafts.

Company profiles are primarily based on public domain information including company URLs. The report profiles 57 companies including many key and niche players such as -

AlloSource
Baxter International
DePuy Synthes Companies
Exactech, Inc.
Integra LifeSciences Holdings Corporation

Note: Product cover images may vary from those shown
2 of 3

BONE GRAFT SUBSTITUTES

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Demineralized Bone Matrix (DBM)
Bone Morphogenetic Protein (BMP)
Stem-Cell Based Bone Grafts
Synthetic Bone Grafts

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Bone Grafts
A Prelude
Increasing Volume of Orthopedic Procedures Present Promising Prospects for Bone Graft Substitutes (BGS) Market
Growing Clinical Use of Bone Graft Substitutes in Surgical Procedures
Rising Popularity of Synthetic Bone Graft Substitutes
Synthetic Bone Grafts Set to Replace Conventional Autografts and Allografts
DBM: Strong Growth but Tough Competition
Bone Morphogenetic Protein
Safety Concerns Affect Growth Prospects
Stem Cell Based Bone Grafts: Promising Growth Ahead
Developing Markets Hold Lucrative Potential for Bone Graft Substitutes
Autograft: The Gold Standard for Bone Grafting Procedures
Allografts: Leading the Race over Autografts
Advanced Allografts Encroaching into the Use of Autografts in Surgical Procedures
Competitive Landscape
Bone Graft Products of Select Players

2. GROWTH DRIVERS, ISSUES & TRENDS
A Review of Major Factors Affecting Growth
Aging Population: A Strong Demographic Driver
Table 1: Global Aging Population in Select Regions/Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart)
Increasing Incidence of Degenerative Intervertebral Disc Diseases
Table 2: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart)
Rising Prevalence of Arthritis and Other Orthopedic Disorders
Growing Number of Revision Orthopedic Surgeries
Rise in Spinal Fusions in Private Healthcare
Applications of Bone Graft Substitutes
An Overview
Spine Fusion
The Largest Application Market for Bone Graft Substitutes
Dental Bone Grafting
A High Potential Market
Table 3: Dental Tissue & Bone Regeneration Materials Market (2015): Percentage Share Breakdown by Segment for Allografts, Synthetics, and Xenografts (includes corresponding Graph/Chart)
What Drives Physicians’ Choice of Bone Grafts?
Challenges for Different Bone Grafts
Patient Safety Emerges as a Top Priority
Growing Volume of Orthopedic Procedures: Opportunity for Bone Graft Substitutes Market
Table 4: Fractures by Age Group (2014): Percentage Share Breakdown of Number of Fractures by Age Group
Table 5: Global Orthopedic Market by Segment (2015E): Percentage Breakdown of Value Sales for Extremities, Hips, Knees, Orthobiologics, Spine, Trauma and Others (includes corresponding Graph/Chart)
Table 6: Worldwide Orthopedics Medical Technology Market (2015E): Percentage Share Breakdown of Revenues by Company for Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, Zimmer Biomet and Others (includes corresponding Graph/Chart)
Orthobiologics Gain Traction in the Bone Grafts Market
Table 7: Global Orthobiologics Market (2015): Percentage Share Breakdown of Revenues by Product
Allografts, Bone Morphogenetic Proteins (BMP), Demineralized Bone Matrix (DBM), Stem Cells, Synthetic Bone Grafts and Viscosupplements (includes corresponding Graph/Chart)
Increasing Visibility of Orthobiological Products to Spur Grafting Options
Spinal Biologics
Bone Graft Substitutes Dominate Market
Technological Advancements Drive Bone Grafts Market
A Glance at Few Recent Innovations/Research Efforts in Bone Grafts
Consortium to Develop SmartBonePep® Bio-hybrid Composite Bone Graft
New Bone Grafting Technique Addresses Shrinkage of Bone due to Tooth Loss
QMUL Researchers Develop Inductigraft Synthetic Bone Grafts
Researchers Develop Aerograft Dental Bone Graft Material for Dental Procedures
Foot and Extremity Reconstruction
Promising Market for Bone Grafts
Precision Machined Allografts Gain Surgeon Preference
Unmet Clinical Needs to Foster R&D Engine
Biological Solutions in Sports Medicine
Beyond Bone Grafting
Disease Transmission through Bone Grafts
A Major Safety Concern
Lack of Standards in Bone Graft Substitute Market
Reimbursement Issues Continue to Haunt Bone Grafts Market
Regional Regulations & Religious Beliefs Hamper Bone Graft Substitutes Market
Synthetic Bone Grafts
Solution for Halal Bone Graft Implantation
Bone Glue
A Potential Threat to the Bone Graft Market
Alliances with Organ Procurement Organizations: A Shot in the Arm
Aging Baby Boomers Render a Decreased Donor Pool
Limited Availability of Donor Tissues
Intense Competition from Alternative Tissue Repair Therapies
Substitute Technologies Threaten to Replace Spinal Fusions
Bone Grafts Termed as Tissues Suffer From Inconsistent Patient Outcomes
Innovations in Orthopedic Biomaterials: A Glance at Developments over the Years
MPCs: Offer Promising Breakthroughs in Bone Graft Substitute
Peptide Signaling Molecules to the Rescue
Prostaglandin Agonists: Emerging From their Drawbacks
Synthetic Bone Grafts
Combination of Bone Marrow and Bone Graft Substitute
Stem Cell Therapy
Bone Morphogenetic Proteins
GEM OS®1 Shows Promise
geneX® Synthetic Bone Graft Substitute
ACCELL Total Bone Matrix
New Ways of Fixing Broken Bones
BoneCure Sleeve
Heading Towards the Human Market
Bioactive Glass
Suitable for Weight Bearing Portion
Tissue Recovery & Processing: A Review
Tissue Banks
Tissue Processing
Tissue Distribution
An Illustration of the Tissue Recovering, Processing, & Distribution Network

3. PRODUCT OVERVIEW
Bone Grafts: A Definition
Bone Grafts: A Peek into their Mechanism of Action
Types of Bone Grafts
Scoring of Osteoconduction, Osteoinduction, and Osteogenesis Properties of Bone Grafts by Type
Autografts
Advantages
Disadvantages
Standard Allografts
Advantages
Disadvantages
Machined Bone Allografts
Demineralized Bone Matrix
Examples of Demineralized Bone Matrix (DBM)
Bone Morphogenetic Proteins (BMPs)
Basic Functions of TGF-Beta
Infuse®
OP-1
Synthetic Bone Grafts
Examples of Synthetic Bone Grafts
Collagen-based Matrices
Ceramic: A Material of Choice
Hydroxyapatite: A Major Calcium Phosphate Based Ceramic
Calcium Sulfate
Polymer Based Bone Grafts
Coral: A Valuable Synthetic Graft Material
Application of Bone Grafts
Spinal Fusion
Trauma & Reconstructive Surgeries
Trauma
Reconstructive Surgeries
Joint Revision Arthroplasty
Oral, Periodontal, and Cranio-Maxillofacial

4. REGULATORY ENVIRONMENT & REIMBURSEMENTS
Regulatory Issues
FDA Classification of Bone Products
Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps)
National Organ Transplant Act (NOTA)
Good Tissue Practices
Tissue Banking Regulation
FDA Regulations on Xenograft
DBM-based Products in US
Synthetic Bone Graft Substitutes

5. PRODUCT INNOVATIONS/INTRODUCTIONS
Citagenix Launches PentOS OI™ Putty Bone Graft Substitute
AlloSource® Introduces ProChondrix® Cartilage Restoration Matrix
AlloSource Wins Patent for AlloStem® Cellular Bone Allograft
OrthoSera Introduces Bone Albumin Bone Substitute
AmnioLife to Introduce Oncor™ DBM
DePuy Synthes Launches VIVIGEN® Cellular Bone Matrix
Stryker Launches BIO4™ Bone Matrix
BONESUPPORT™ Gains Approval for Marketing CERAMENT™ in India
DePuy Synthes Launches ViviGen™ Cellular Bone Matrix
RTI Surgical Launches Precision Allograft Cartilage Kit
RTI Surgical Announces Human Implantation of map3® Cellular Allogeneic Bone Graft Strips
Zimmer Spine Introduces Puros Demineralized Bone Matrix (DBM) Range
RTI Surgical Introduces New Natural Bone Grafting Solutions
Nobel Biocare Introduces creos™ Allograft Regenerative Solution
DePuy Synthes Spine Introduces CONFORM SHEET™ in the US

6. RECENT INDUSTRY ACTIVITY
AllowSource Receives Patent for ProChondrix® Cartilage Restoration Matrix
MiMedx Group Takes Over Stability Biologics
Wright Medical Merges with Tornier
AlloSource Wins Patent for Acellular Human Dermal Matrix
AlloSource Bags Patent for AlloStem® Cellular Bone Allograft
Medtronic Gains FDA Approval for Infuse® Bone Graft for New Spine Surgery Indications
Bioventus Takes Over BioStructures LLC
NuVasive Gains FDA Approval for Cervical Corpectomy Cage
BioMimetic Wins FDA (PMA) Approval for AUGMENT® Bone Graft
Zimmer Merges with Biomet to Create Zimmer Biomet Holdings
NovaBone Gains FDA Approval for NovaBone MacroFORM MIS Delivery System™
Osiris Therapeutics and Stryker in Exclusive Partnership
Wright Medical Gains FDA (PMA) Approval for Augment® Bone Graft
Zimmer Takes Over ETEX Holdings
Wright Medical Acquires BioMimetic
RTI Biologics Acquires Pioneer® Surgical Technology

7. FOCUS ON SELECT PLAYERS
AlloSource (USA)
Baxter International, Inc. (USA)
DePuy Synthes Companies (USA)
Exactech, Inc. (USA)
Integra LifeSciences Holdings Corporation (USA)
LifeNet Health, Inc. (USA)
Medtronic plc (Ireland)
NovaBone Products LLC (USA)
NuVasive, Inc. (USA)
Orthofix International N V (Curaçao)
RTI Surgical, Inc. (USA)
Smith & Nephew Plc (UK)
Stryker Corporation (USA)
Wright Medical Group N.V. (Netherlands)
Zimmer Biomet Holdings, Inc. (USA)

8. GLOBAL MARKET PERSPECTIVE
Table 8: World Recent Past, Current and Future Analysis for Bone Graft Substitutes by Geographic Region/Country
US, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 9: World Historic Review for Bone Graft Substitutes by Geographic Region/ Country
US, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 10: World 14-Year Perspective for Bone Graft Substitutes by Geographic Region/Country
Percentage Breakdown of Revenues for US, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Bone Graft Substitutes Market: Promising Opportunities Ahead
Aging Population: A Weighty Demographic Growth Factor
Table 11: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart)
Table 12: US Population Breakdown by Age Group (2015) (includes corresponding Graph/Chart)
Rising Incidence of Degenerative Intervertebral Disc Diseases
Back Pain
Arthritis
Table 13: % of Population Diagnosed with Arthritis by Age Group (includes corresponding Graph/Chart)
Osteoporosis
Table 14: Osteoporosis Population in the US: 2002, 2005, 2008 & 2012 (includes corresponding Graph/Chart)
Table 15: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart)
Rise in Revision Orthopedic Surgeries Bodes Well for Bone Graft Substitutes Market
Unmet Clinical Needs to Foster R&D Engine
Synthetic Bone Grafts to Fan Growth
Orthopedic Growth Factors Market
Safety Concerns of INFUSE® Affect Growth
Stem Cell Bone Grafts: A Promising Segment in BGS Market
Spinal Surgery Market: Opportunity for Bone Grafts Market
Dental Bone Graft Substitutes Market: An Overview
Orthopedic Biomaterials Market
An Overview
Orthobiologics Market
Overview
Regulatory Challenges Limit Growth in the Bone Graft Substitutes
Competitive Scenario
Table 16: US Market for Bone Graft Substitutes (2014): Percentage Market Share Breakdown of Leading Suppliers for Bacterin, DePuy Synthes, LifeNet, Medtronic, MTF, NuVasive, Stryker and Others (includes corresponding Graph/Chart)
Table 17: US Market for Synthetic Bone Grafts (2014): Percentage Market Share Breakdown of Leading Suppliers for Baxter, DePuy Synthes, Integra, Medtronic, NuVasive, and Stryker (includes corresponding Graph/Chart)
Table 18: US Market for Allografts Demineralized Bone Matrix (DBM) (2014): Percentage Market Share Breakdown of Leading Suppliers for Bacterin, Integra, LifeNet, Medtronic, MTF and Others (includes corresponding Graph/Chart)
Table 19: US Market for Cell-based Combinations Bone Graft Substitutes (2014): Percentage Market Share Breakdown of Leading Suppliers for MTF and NuVasive (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 20: US Recent Past, Current and Future Analysis for Bone Graft Substitutes by Product Segment
Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Stem Cell Based Grafts, and Synthetic Bone Grafts Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 21: US Historic Review for Bone Graft Substitutes by Product Segment
Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Stem Cell Based Grafts, and Synthetic Bone Grafts Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 22: US 14-Year Perspective for Bone Graft Substitutes by Product Segment
Percentage Breakdown of Revenues for Demineralized Bone Matrix (DBM), Bone Morphogenetic Protein (BMP), Stem Cell Based Grafts, and Synthetic Bone Grafts Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

2. JAPAN
A.Market Analysis
Current and Future Analysis
Dental Bone Graft Substitutes Market
Table 23: Dental Bone Graft Substitutes Market in Japan (2015E): Percentage Share Breakdown of Volume Sales for Synthetic Graft and Xenograft (includes corresponding Graph/Chart)
B.Market Analytics
Table 24: Japanese Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 25: Japanese Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3. EUROPE
A.Market Analysis
European Market for Bone Graft Substitutes: An Overview
Table 26: European Bone Graft Substitutes Market (2012): Percentage Share Breakdown of Value Sales for Synthetic, Allograft, and DBM (includes corresponding Graph/Chart)
Synthetic Bone Graft Drives the BGS Market
Bone Morphogenetic Protein (BMP) Market
Orthopedic Biomaterials Market
An Overview
Dental Biomaterials Market in Europe: An Insight
Regulatory Overview
EU Directive 2003/32/EC
DBM-based Products in Europe
B.Market Analytics
Table 27: European Recent Past, Current and Future Analysis for Bone Graft Substitutes by Geographic Region/Country
France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 28: European Historic Review for Bone Graft Substitutes by Geographic Region/Country
France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 29: European 14-Year Perspective for Bone Graft Substitutes by Geographic Region/ Country
Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

3a. FRANCE
Market Analysis
Table 30: French Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 31: French Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3b. GERMANY
Market Analysis
Table 32: German Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 33: German Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3c. ITALY
Market Analysis
Table 34: Italian Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 35: Italian Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3d. THE UNITED KINGDOM
A.Market Analysis
Current and Future Analysis
Key Player
B.Market Analytics
Table 36: UK Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 37: UK Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3e. SPAIN
Market Analysis
Table 38: Spanish Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 39: Spanish Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

3f. REST OF EUROPE
A.Market Analysis
Current and Future Analysis
Product Launches
Strategic Corporate Developments
Select Players
B.Market Analytics
Table 40: Rest of Europe Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 41: Rest of Europe Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC
A.Market Analysis
Current and Future Analysis
Dental Bone Graft Substitutes Market in Asia-Pacific
An Overview
Table 42: Leading Players in the Dental Bone Graft Substitutes Market in Asia-Pacific (2015E): Percentage Share Breakdown of Sales for Geistlich and Others (includes corresponding Graph/Chart)
Table 43: Over 65 Years Individuals as % of Total Population in Select Asian Countries (2015) (includes corresponding Graph/Chart)
B.Market Analytics
Table 44: Asia-Pacific Recent Past, Current and Future Analysis for Bone Graft Substitutes by Geographic Region/Country
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 45: Asia-Pacific Historic Review for Bone Graft Substitutes by Geographic Region/Country
China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 46: Asia-Pacific 14-Year Perspective for Bone Graft Substitutes by Geographic Region/Country
Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

4a. CHINA
A.Market Analysis
Market Overview
Table 47: Dental Bone Graft Substitutes Market in China (2015E): Percentage Share Breakdown of Volume Sales by Segment
Allograft, Synthetic Graft and Xenograft (includes corresponding Graph/Chart)
B.Market Analytics
Table 48: Chinese Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 49: Chinese Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4b. INDIA
A.Market Analysis
Current and Future Analysis
Product Approval
B.Market Analytics
Table 50: Indian Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 51: Indian Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

4c. REST OF ASIA-PACIFIC
A.Market Analysis
Current and Future Analysis
Focus on Select Regional Markets
Australia
Table 52: Dental Bone Graft Substitutes Market in Australia (2020P): Percentage Share Breakdown of Volume Sales by Segment
Demineralized Allografts, Mineralized Allografts, Synthetic Grafts, and Xenografts (includes corresponding Graph/Chart)
Malaysia
South Korea
Table 53: Dental Bone Graft Substitutes Market in South Korea (2015E): Percentage Share Breakdown of Volume Sales by Material
Allograft, Synthetic Graft and Xenograft (includes corresponding Graph/Chart)
Singapore
B.Market Analytics
Table 54: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 55: Rest of Asia-Pacific Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

5. LATIN AMERICA
A.Market Analysis
Current and Future Analysis
Dental Bone Graft Substitutes Market
Overview
Overview of Brazilian Orthopedic Devices Market
Select Player
B.Market Analytics
Table 56: Latin American Recent Past, Current and Future Analysis for Bone Graft Substitutes by Geographic Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 57: Latin American Historic Review for Bone Graft Substitutes by Geographic Region
Brazil and Rest of Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 58: Latin American 14-Year Perspective for Bone Graft Substitutes by Geographic Region
Percentage Breakdown of Revenues for Brazil and Rest of Latin America Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)

6. REST OF WORLD
A.Market Analysis
Current and Future Analysis
Canada
Product Launch
B.Market Analytics
Table 59: Rest of World Recent Past, Current and Future Analysis for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 60: Rest of World Historic Review for Bone Graft Substitutes Market Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 57 (including Divisions/Subsidiaries 61)
The United States (39)
Canada (1)
Europe (17)
- France (2)
- Germany (2)
- The United Kingdom (4)
- Rest of Europe (9)
Asia-Pacific (Excluding Japan) (3)
Africa (1)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Cache

Our Clients

  • Sigma-Aldrich Corporation
  • Evonik Industries AG
  • BASF SE
  • Bayer AG
  • Heraeus Medical Components
  • Wright Medical Group